Current Ratio of Aspire Biopharma Holdings, Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aspire Biopharma Holdings, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Aspire Biopharma Holdings, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 15%, a 340% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Aspire Biopharma Holdings, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 15% +12% +340% 30 Sep 2025
Q2 2025 11% +3.3% +42% 30 Jun 2025
Q1 2025 10% -16% -60% 31 Mar 2025
Q4 2024 3.6% -128% -97% 31 Dec 2024
Q3 2024 3.5% -219% -98% 30 Sep 2024
Q2 2024 7.8% -319% -98% 30 Jun 2024
Q1 2024 26% -412% -94% 31 Mar 2024
Q4 2023 131% -552% -81% 31 Dec 2023
Q3 2023 222% -352% -61% 30 Sep 2023
Q2 2023 326% 30 Jun 2023
Q1 2023 438% 31 Mar 2023
Q4 2022 683% 31 Dec 2022
Q3 2022 575% 30 Sep 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.